Evidence map›Paper›PMID 25124854›Full record

ArticleThe American journal of psychiatry2014

Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age.

Anthony S Zannas, Douglas R McQuoid, Martha E Payne, James R MacFall, Allison Ashley-Koch, David C Steffens, Guy G Potter, Warren D Taylor

Open access · greenAbstract read
In one paragraph

Article in The American journal of psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Baby brain atlases.NeuroImage · 2019
    Review
  10. Review
  11. Strategies for dementia prevention: latest evidence and implications.Therapeutic advances in chronic disease · 2017
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anthony S ZannasFrom the Department of Psychiatry and Behavioral Sciences, the Neuropsychiatric Imaging Research Laboratory, the Department of Radiology, the Center for Human Genetics, and the Department of Medicine, Duke University Medical Center, Durham, N.C.; the Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany; the Department of Psychiatry, University of Connecticut Health Sciences Center, Farmington, Conn.; and the Department of Psychiatry, Vanderbilt University Medical Center and The Geriatric Research, Education, and Clinical Center (GRECC), Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, Tenn.
Douglas R McQuoid
Martha E Payne
James R MacFall
Allison Ashley-Koch
David C Steffens
Guy G Potter
Warren D Taylor
Max Planck Institute of Psychiatry · DE

Funding

Geriatric Depression: Risk Factors for Adverse OutcomesR01MH054846 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI STEFFENS, DAVID C. · 1995 to 2016
$10.1M
Genes and Alterations in Brain Structure and Function in DepressionR01MH077745 · NIMH · VANDERBILT UNIVERSITY · PI TAYLOR, WARREN D · 2008 to 2012
$2.6M
Midcareer Investigator Award in Geriatric DepressionK24MH070027 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI STEFFENS, DAVID C. · 2004 to 2013
$1.6M
NIMH NIH HHS K24 MH070027NIMH NIH HHS R01 MH054846NIMH NIH HHS R01 MH077745
6 · The paper itself

Abstract

objectiveGenetic factors confer risk for neuropsychiatric phenotypes, but the polygenic etiology of these phenotypes makes identification of genetic culprits challenging. An approach to this challenge is to examine the effects of genetic variation on relevant endophenotypes, such as hippocampal volume loss. A smaller hippocampus is associated with gene variants of the renin-angiotensin system (RAS), a system implicated in vascular disease. However, no studies to date have investigated longitudinally the effects of genetic variation of RAS on the hippocampus.

methodThe authors examined the effects of polymorphisms of AGTR1, the gene encoding angiotensin-II type 1 receptor of RAS, on longitudinal hippocampal volumes of older adults. In all, 138 older adults (age ≥60 years) were followed for an average of about 4 years. The participants underwent repeated structural MRI and comprehensive neurocognitive testing, and they were genotyped for four AGTR1 single-nucleotide polymorphisms (SNPs) with low pairwise linkage disequilibrium values and apolipoprotein E (APOE) genotype.

resultsGenetic variants at three AGTR1 SNPs (rs2638363, rs1492103, and rs2675511) were independently associated with accelerated hippocampal volume loss over the 4-year follow-up period in the right but not left hemisphere. Intriguingly, these AGTR1 risk alleles also predicted worse episodic memory performance but were not related to other cognitive measures. Two risk variants (rs2638363 and rs12721331) interacted with the APOE4 allele to accelerate right hippocampal volume loss.

conclusionsRisk genetic variants of the RAS may accelerate memory decline in older adults, an effect that may be conferred by accelerated hippocampal volume loss. Molecules involved in this system may hold promise as early therapeutic targets for late-life neuropsychiatric disorders.

Indexed as

AgingLinkage DisequilibriumMemory, EpisodicPolymorphism, Single NucleotideAgedAged, 80 and overApolipoprotein E4Cognition DisordersEndophenotypesFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic VariationHippocampusHumansMaleAGTR1 protein, humanApolipoprotein E4Receptor, Angiotensin, Type 1

Identifiers

PMID25124854
PMCPMC4329281
OpenAlexW2144395353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.